Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Medical Imaging

Background:

• Arrhythmogenic cardiomyopathy (ACM) is a spectrum of myocardial diseases characterized by fibrotic or fibrofatty replacement.
• Arrhythmogenic left ventricular cardiomyopathy (ALVC) specifically affects the left ventricle, causing ventricular arrhythmias.
• Diagnostic criteria for ALVC exist but require genetic testing for confirmation due to overlapping features with other cardiac conditions.

Purpose of the Study:

• To review the role of multimodality imaging in diagnosing arrhythmogenic left ventricular cardiomyopathy (ALVC).
• To highlight the importance of various imaging techniques in ALVC diagnosis, risk stratification, and management.

Main Methods:

• Review of current literature on arrhythmogenic left ventricular cardiomyopathy (ALVC).
• Discussion of multimodality imaging techniques including echocardiography, cardiac magnetic resonance, and nuclear imaging.
• Emphasis on the integration of genetic testing for diagnostic confirmation.

Main Results:

• Multimodality imaging provides crucial data for ALVC diagnosis and differential diagnosis.
• Imaging aids in risk stratification for sudden cardiac death in ALVC patients.
• Genetic testing is essential for confirming ALVC diagnosis, especially when imaging findings overlap with other cardiomyopathies.

Conclusions:

• Multimodality imaging is indispensable for the comprehensive evaluation of patients with arrhythmogenic left ventricular cardiomyopathy (ALVC).
• The integration of advanced imaging with genetic analysis improves diagnostic accuracy and patient management for ALVC.
• Further research into optimizing imaging protocols and understanding disease mechanisms in ALVC is warranted.